Patent ID: 11930808
Assignee: CITOSPIN, S.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. A composition comprising a population of at least 0.5×106 mesenchymal stem cells and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 0.25 mM to 1 mM obtainable according to the method of claim 1, wherein said mesenchymal stem cells retain for at least 72 hours during hypothermic transport at 2-8° C., the characteristics of fresh mesenchymal stem cells, including:
showing adherence to plastic;
presenting a viability of at least 70%;
presenting an expression ≥90% of CD90, CD 166, CD73 and CD105;
presenting an expression ≤10% of CD14, CD34, CD45 and HLA-DR≤10%;
not featuring chromosomal aberrations; and
presenting capacity to differentiate into osteoblasts, adipocytes and chondrocytes.